Neither tumor burden, as assessed by HE staining, nor tumor cell proliferation, as assessed by % proliferating cell nuclear antigen (PCNA)-positive cells within tumors, revealed significant differences between KPGEMM and KPCRISPR (Figures 1D,E). Here, PCNA is linked to neoplasm.